Veradermics, Inc (MANE): Total Assets
$152.62M
As of 2025-12-31
$825.74M
As of 2026-06-30
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $152.62M | +174.8% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $55.53M | n/a | 2026-03-30, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Veradermics, Inc (MANE) | 2025-12-31 | $152.62M | +174.8% |
| CytomX Therapeutics, Inc. (CTMX) | 2025-12-31 | $151.57M | +25.7% |
| Ovid Therapeutics Inc. (OVID) | 2025-12-31 | $150.93M | +63.8% |
| Whitehawk Therapeutics, Inc. (WHWK) | 2025-12-31 | $150.83M | +114.5% |
| Xilio Therapeutics, Inc. (XLO) | 2025-12-31 | $154.69M | +117.6% |
| XBiotech Inc. (XBIT) | 2025-12-31 | $150.08M | -24.6% |
| Precigen, Inc. (PGEN) | 2025-12-31 | $155.50M | +7.0% |
| Boundless Bio, Inc. (BOLD) | 2025-12-31 | $157.06M | -23.9% |
| Larimar Therapeutics, Inc. (LRMR) | 2025-12-31 | $145.84M | -27.2% |
Compare MANE, CTMX, OVID, WHWK side by side · Screen every company in Pharmaceutical Preparations ↗